Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ATAI Life Sciences N.V. - Common Shares (NQ:ATAI)

1.445 +0.055 (+3.96%)
Streaming Delayed Price Updated: 2:13 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ATAI Life Sciences N.V. - Common Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
27 28 Next >
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 17.87% at $1.22 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 23, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 5.33% at $14.24 
Via Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 10.34% at $0.16 
Via Benzinga
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 29.35% at $0.14 LOSERS: 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
  
Via Benzinga
Psychedelic Stock Gainers And Losers From August 17, 2022
  
Via Benzinga
Psychedelic Stock Gainers And Losers From August 16, 2022
  
Via Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility... 
Via Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
  
Via Benzinga
Recap: ATAI Life Sciences Q2 Earnings
  ATAI Life Sciences (NASDAQ:ATAI) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Major Psychedelic Stocks Down This Week; Still Up Since End Of June
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then. 
Via Talk Markets
Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today
  
Via Benzinga
ATAI Life Sciences Earnings: A Preview
  ATAI Life Sciences (NASDAQ:ATAI) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. 
Via Benzinga
Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today
  
Via Benzinga
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 10, 2022
  
Via Benzinga
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... 
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today
  
Via Benzinga
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 4, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17 
Via Benzinga
Cathie Wood Continues Investing In Psychedelics, She Bought Over 3M Atai Shares In July Alone
Several weeks ago, Cathie Wood's ARK Fund (BATS: ARKG) invested in the biotech psychedelics sector, specifically in major player 
Via Benzinga
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82 
Via Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34 
Via Benzinga
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From July 29, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22 
Via Benzinga
InvestorNewsBreaks – Atai Life Sciences (NASDAQ: ATAI) Featured in Analysis Report
Via Investor Brand Network
Topics Derivatives
Exposures Derivatives
Allied, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55 
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06 
Via Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55 
Via Benzinga
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam... 
Via FinancialNewsMedia
Topics Law Enforcement
Exposures Legal
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.